PPAJX | VIVIX | PPAJX / VIVIX | |
Total Expense Ratio | 0.48 | 0.04 | 1,200% |
Annual Report Gross Expense Ratio | 0.52 | 0.04 | 1,300% |
Fund Existence | 2 years | 27 years | - |
Gain YTD | -1.787 | 6.215 | -29% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 311M | 195B | 0% |
Annual Yield % from dividends | 3.59 | 2.19 | 164% |
Returns for 1 year | -8.56 | 7.77 | -110% |
Returns for 3 years | N/A | 29.94 | - |
Returns for 5 years | N/A | 72.23 | - |
Returns for 10 years | N/A | 114.03 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GILLX | 23.91 | 0.01 | +0.04% |
Goldman Sachs Enhanced U.S. Equity Inst | |||
FBTAX | 28.16 | N/A | N/A |
Fidelity Advisor Biotechnology A | |||
PFPWX | 57.55 | N/A | N/A |
Parnassus Value Equity Institutional | |||
NZDCHF | 0.48 | N/A | N/A |
New Zealand Dollar - Switzerland Franc | |||
SVPSX | 81.23 | -0.25 | -0.31% |
ProFunds Small Cap Value Svc |